Literature DB >> 33200651

Executive function in children with sickle cell anemia on transfusion: NIH toolbox utility in the clinical context.

M Downes1, L Keenan1, Y Duane2, K Duffy1,2, G Fortune2, R Geoghegan2, H Conroy2, C McMahon2.   

Abstract

Objective: The aim of this study was to establish the utility of the NIH Toolbox as a cognitive screener of executive functions in the clinical context. Additionally, we aimed to investigate whether age and time on transfusion were related to executive function performance. Method: Twenty-eight children and adolescents with sickle cell anemia (SCA) between 8 and 18 years (M = 13.28, SD = 3.05) on transfusion treatment were included. Participants completed five NIH Toolbox tasks (three executive function tasks and two non-executive function control tasks).
Results: Mean scores on one of the three executive function measures (inhibitory control) fell below the average range (M = 81.36, SD = 14.01) with approximately 70% of children from both groups below the average range. Scores for processing speed (M = 86.82, SD = 22.01) and cognitive flexibility (M = 85.75, SD = 12.67) were low averages. As expected, scores on non-executive measures (language and memory) fell within the average range. No significant differences were observed between children with silent stroke and no stroke on executive function measures. Older age (p < .01) and length of time on transfusion (p < .05) predicted lower inhibitory control scores. Conclusions: Findings provide evidence for poor development of inhibitory control with age in this patient population. As the NIH Toolbox successfully highlighted expected deficits in this patient population, this study supports the use of this tool as a brief screening measure for children with SCD. The clinical and theoretical implications of the findings are discussed.

Entities:  

Keywords:  NIH Toolbox; cognitive flexibility; executive function; inhibition; processing speed; sickle cell anemia; transfusion

Mesh:

Year:  2020        PMID: 33200651     DOI: 10.1080/13854046.2020.1847325

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   4.373


  3 in total

Review 1.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

2.  Quantification of Silent Cerebral Infarction on High-Resolution FLAIR and Cognition in Sickle Cell Anemia.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Jonathan D Clayden; Dawn E Saunders; Anna M Hood; Melanie Koelbel; Sati Sahota; David C Rees; Olu Wilkey; Mark Layton; Maria Pelidis; Baba P D Inusa; Jo Howard; Subarna Chakravorty; Chris A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

3.  Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study.

Authors:  Jennifer M Lye; Julia A Knight; Jasleen Arneja; Ryan A Seeto; Jody Wong; Nadya Adel Khani; Jennifer D Brooks; Robert D Levitan; Stephen G Matthews; Stephen J Lye; Rayjean J Hung
Journal:  Pediatr Res       Date:  2022-07-07       Impact factor: 3.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.